Immunoablation followed or not by hematopoietic stem cells as an intense therapy for severe autoimmune diseases (SADS). New perspectives, new problems

Haematologica

Volumn 85, Issue 11 SUPPL., 2000, Pages 71-80

  Marmont, A M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOABLATION; JUVENILE RHEUMATOID ARTHRITIS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; POSTOPERATIVE PERIOD; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOCYTOPENIC PURPURA;

ANIMALS; AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS;

EID: 0033694555     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Epidemiology and estimated population burden of slected autoimmune diseases in the United States
2. Autoimmune diseases: The failure of self-tolerance
3. Foreword-the use of autoantibodies
4. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases
5. Autoantibodies and autoimmunity: A three decade perspective
6. An outsider's view on SLE research
7. Prospects of stem cell transplantation in autoimmune diseases
8. Treatment- Resistant Rheumatic Disease Rheum
9. Perspective: Immunoablation with stem cell rescue: A possible cure for systemic lupus erythematosus
10. Treatment of life-threatening autoimmune disease with myeloablative doses of immunodepressive agents: Experimental background and rationale for ABMT
11. Review: BMT in experimental autoimmune diseases
12. Bone marrow transplantation for autoimmune diseases
13. Stem cell transplantation in experimental models of autoimmune disease
14. Haematopoietic stem cell transplantation for autoimmune diseases
15. Stem cell transplantation for severe autoimmune diseases: Progress and problems
16. Stem cell transplantation - A cure for autoimmune diseases
17. Hematopoietic stem cell therapy of autoimmune diseases
18. Short analytical review. New opportunities for treatment of severe autoimmune diseases: Bone marrow transplantation
19. Autologous and allogeneic stem cell transplantation for the treatment of autoimmune diseases as a potential new approach
20. New horizons in the treatment of autoimmune diseases: Immunoablation and stem cell transplantation
21. Hematopoietic Stem Cell Transplantation for Severe Autoimmune Disease: Know Thyself
22. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice
23. The immunobiology of T cell therapies for leukemias
24. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice
25. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice
26. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation
27. Effective treatment of relapsing autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation
28. Autoimmunity and bone marrow transplantation
29. Autoimmune diseases and autoimmunity post-bone marrow transplantation
30. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia
31. Bone marrow transplantation for rheumatoid arthritis
32. Pre-existing autoimmune disease in patients with long term survival after allogeneic bone marrow transplantation: Seattle experience
33. Does hemopoietic stem cell transplantation have a role in treatment of severe rheumatoid arthritis?
34. Progression of rheumatoid arthritis following bone marrow transplantation: A case report with 13-years follow-up
35. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation
36. Course of Crohn's disease after allogeneic bone marrow transplantation: Report of 6 cases
37. Immune ablation and stem cell transplantation for severe Evans syndrome and refractory thrombocytopenic purpura
38. Treatment of severe Evans' syndrome with an allogeneic cord blood transplant
39. Resolution of immune hemolytic anaemia with allogeneic bone marrow transplantation after unsuccessful autograft
40. Bood and marrow stem cell transplantation in autoimmune diseases: A consensus report written on behalf of European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation
41. Haemopoietic precursor-cell transplants for autoimmune diseases
42. Autologous hematopoietic stem cell transplantation for autoimmune disease-feasibility and transplant-related mortality
43. High-dose immunosuppressive therapy for rheumatoid arthritis: Some answers, more questions
44. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
45. Is multiple sclerosis an autoimmune disease?
46. T-cell immunity in multiple sclerosis
47. Peripheral blood cell transplantation in the treatment of progressive multiple sclerosis: First results of a pilot study
48. Autologous stem cell transplantation in progressive multiple sclerosis. An interim analysis of efficacy
49. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation
50. High-dose immunosuppressive therapy with PRBC support in the treatment of poor risk systemic sclerosis
51. Bone marrow transplantation in multiple sclerosis
52. A multi-center longitudinal study corn paring the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis
53. Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: A consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation
54. Autologous bone marrow transplantation for rheumatoid arthritis
55. A randomized, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for hematopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis
56. A phase I-II escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis
57. Intensified dose (4 mg/mq) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilisation in refractory rheumatoid arthritis
58. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis
59. High-dose Chemotherapy and syngeneic hematopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis
60. Autologous haematopoietic stem cell transplantation in four patients with refractory juvenile chronic arthritis
61. Haematopoietic stem cell transplantation for juvenile chronic arthritis
62. Hemophagocytic lymphohistiocytis: Still a morphological diagnosis
63. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis
64. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: Regression of both diseases after autologous bone marrow transplantation
65. Prolonged remission of long-standing lupus erythematosus after autologous bone marrow transplant for non-Hodgink's lymphoma
66. Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation
67. Early recurrence or persistence of autoimmune disease after unmanipulated autologous stem cell transplantation
68. Autologous marrow stem cell transplantation for systemic lupus erythematosus of long duration
69. Hematopoietic stem cell transplantation for systemic lupus erythematosus
70. Autologous peripheral blood stem and progenitor (CD 34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome
71. Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD 34+ purified autologous stem cell from peripheral blood
72. Treatment of severe systemic lupus erythematosus with high dose chemotherapy and haemopoietic stem-cell transplantation: A phase I study
73. Classification, prognosis
74. Autologous haematopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease
75. Treatment of systemic sclerosis with autologous haematopoietic cell transplantation
76. High-dose immunosuppressive therapy (HDIT) using total body irradiation (TBI), cyclophosphamide (CY) and ATG with autologous CD 34+ selected peripheral blood stem cell (PBSC) rescue as treatment for severe systemic sclerosis
77. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis
78. Therapy for adults with refractory chronic immune thrombocytopenic purpura
79. Peripheral stem cell mobilization in a refractory autoimmune Evans syndrome: A cautionary case report
80. Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenia
81. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia
82. Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura
83. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation
84. Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation
85. Complete remission in severe aplastic anemia after high dose cyclophosphamide without bone marrow transplantation
86. Immunoablative high dose cyclophosphamide without stem cell rescue for refractory, severe autoimmune disease
87. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity
88. 'Sustained remission' in a case of SLE following megadose cylophosphamide
89. CD 34+ cell selection and ex vivo expansion in autologous and allogeneic transplantation
90. Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded autologous CD 34 positive cells
91. BMT beats autoimmune disease
92. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation
93. T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review
94. Remission and immune reconstitution after T-cell depleted stem cell transplantation for rheumatoid arthritis
95. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD 34 + hematopoietic progenitors
96. Essential role of the thymus to reconstitute naive (CD4RA+) T-helper cells after human allogeneic bone marrow transplantation
97. Assessment of thymic output in adults after haematopoietic stem cell transplantation and prediction of T-cell reconstitution
98. Constraints on CD + recovery postchemotherapy in adults: Thymicin-sufficiency and apoptotic decline of expanded peripheral CD + cells
99. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults
100. Results of allogeneic bone marrow transplantation for acute leukaemia have improved over time in Europe
101. Nonmyeloablative stem cell transplantation and cell therapy as ana alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic disease
102. Transplantlite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
103. Nonmyeloablative preparative regimens: Experimental data and clinical practice
104. Stem cell transplantation for severe autoimmune diseases: New proposals but still unanswered questions
105. Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphoytes specific for WTI
106. A revised estimate of twin concordance in systemic lupus erythematosus
107. The genetics of human lupus
108. Systemic lupus erythematosus
109. Reprogramming the immune system
110. Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease
111. Eppur si muove (Galileo Galilei 1564-1642): The idiotypic dysregulation of autoantibodies as part of the etiology of SLE
112. Solid cancers after bone marrow transplantation
113. Incidence and characterization of secondary mylodisplastic syndrome and acute myelogenous leukemia following high-dose radiochemotherapy and autologous stem cell transplantation for lymphoid malignancies
114. Trial of intravenous pulse cyclophosphamide and methilprenisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis
115. Randomised double-blind placebo-controlled study of interferon beta-1 a in relapsing/remitting multiple sclerosis